<DOC>
	<DOCNO>NCT00139568</DOCNO>
	<brief_summary>Tegaserod aminoguanidine indole compound member new class 5-hydroxytryptamine ( 5-HT ) agonist . Activation 5-HT4 receptor trigger release neurotransmitter enteric nerve turn stimulate contractility peristalsis . This study investigate efficacy safety tegaserod chronic constipation Chinese population adult men woman</brief_summary>
	<brief_title>An Evaluation Efficacy Safety Tegaserod 6 mg Bid Given Orally Chinese Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>Men woman least 18 year age History constipation least 6 month prior screen Normal bowel evaluation perform within past 5 year Most bothersome symptom last 6 month abdominal pain/discomfort Whose chronic constipation think result bowel surgery , gynecological surgery , neurologic disorder , systemic sclerosis , amyloidosis , scleroderma , myotonic dystrophy Insulin dependent diabetes Evidence cathartic colon laxative abuse Other inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Chronic constipation</keyword>
	<keyword>5-HT,5-HT4 ,</keyword>
	<keyword>functional GI</keyword>
	<keyword>China</keyword>
	<keyword>tegaserod</keyword>
</DOC>